AU2001259160A1 - Compositions and methods for the identification, assessment, prevention, and therapy of human cancers - Google Patents
Compositions and methods for the identification, assessment, prevention, and therapy of human cancersInfo
- Publication number
- AU2001259160A1 AU2001259160A1 AU2001259160A AU5916001A AU2001259160A1 AU 2001259160 A1 AU2001259160 A1 AU 2001259160A1 AU 2001259160 A AU2001259160 A AU 2001259160A AU 5916001 A AU5916001 A AU 5916001A AU 2001259160 A1 AU2001259160 A1 AU 2001259160A1
- Authority
- AU
- Australia
- Prior art keywords
- assessment
- therapy
- prevention
- compositions
- identification
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 206010028980 Neoplasm Diseases 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 230000002265 prevention Effects 0.000 title 1
- 238000002560 therapeutic procedure Methods 0.000 title 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
- G01N33/57496—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving intracellular compounds
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Cell Biology (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Toxicology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US20070100P | 2000-04-28 | 2000-04-28 | |
| US60200701 | 2000-04-28 | ||
| US20633900P | 2000-05-23 | 2000-05-23 | |
| US60206339 | 2000-05-23 | ||
| PCT/US2001/013406 WO2001084156A2 (en) | 2000-04-28 | 2001-04-26 | Identification, assessment, prevention, and therapy of human cancers |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2001259160A1 true AU2001259160A1 (en) | 2001-11-12 |
Family
ID=26896015
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2001259160A Abandoned AU2001259160A1 (en) | 2000-04-28 | 2001-04-26 | Compositions and methods for the identification, assessment, prevention, and therapy of human cancers |
Country Status (3)
| Country | Link |
|---|---|
| US (1) | US20020015956A1 (en) |
| AU (1) | AU2001259160A1 (en) |
| WO (1) | WO2001084156A2 (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2004136990A (en) * | 2002-05-17 | 2005-08-10 | Байлор Колледж Оф Медсин (Us) | DIFFERENTIAL PICTURES OF EXPRESSION OF GENES WHICH PREDICT CHEMOSENSITIVITY AND CHEMORESISTANCE TO DOCETEXAXEL |
| US20100261292A1 (en) * | 2009-04-10 | 2010-10-14 | Meso Scale Technologies, Llc | Methods for Conducting Assays |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2002508652A (en) * | 1996-08-23 | 2002-03-19 | ヒューマン ジノーム サイエンシーズ,インコーポレイテッド | Novel human growth factor |
| JP2002503822A (en) * | 1998-02-18 | 2002-02-05 | セライト リミテッド | Cancer Treatment |
-
2001
- 2001-04-26 AU AU2001259160A patent/AU2001259160A1/en not_active Abandoned
- 2001-04-26 US US09/843,473 patent/US20020015956A1/en not_active Abandoned
- 2001-04-26 WO PCT/US2001/013406 patent/WO2001084156A2/en active Application Filing
Also Published As
| Publication number | Publication date |
|---|---|
| WO2001084156A2 (en) | 2001-11-08 |
| WO2001084156A3 (en) | 2002-05-23 |
| US20020015956A1 (en) | 2002-02-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2002322280A1 (en) | Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer | |
| AU2001236519A1 (en) | Identification, assessment, prevention, and therapy of prostate cancer | |
| AU6147401A (en) | Compositions and methods for the treatment of cancer | |
| AU2001251613A1 (en) | Novel genes, compositions and methods for the identification, assessment, prevention, and therapy of human cancers | |
| AU2001229340A1 (en) | Genes compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer | |
| AU2001268259A1 (en) | Compositions and methods for the therapy and diagnosis of colon cancer | |
| AU2001269766A1 (en) | Compositions and methods for the therapy and diagnosis of colon cancer | |
| AU2002219782A1 (en) | Diindolylmethane and c-substituted diindolylmethane compositions and methods for the treatment of multiple cancers | |
| AU2495200A (en) | Compositions and methods for the treatment of tumor | |
| AU2003200722A1 (en) | Compositions and methods for the treatment of tumor | |
| AU2003200740A1 (en) | Compositions and methods for the treatment of tumor | |
| AU2003200731A1 (en) | Compositions and methods for the treatment of tumor | |
| AU2001261007A1 (en) | Compositions and methods for the therapy and diagnosis of lung cancer | |
| AU2001245295A1 (en) | Methods and compositions for the identification, assessment, prevention and therapy of human cancers | |
| AU2001280982A1 (en) | Compositions and methods for the therapy and diagnosis of colon cancer | |
| AU2002303219A1 (en) | Compositions and methods for the therapy and diagnosis of cancer | |
| AU2002246519A1 (en) | Compositions and methods for the therapy and diagnosis of colon cancer | |
| AU7701100A (en) | Compositions, kits, and methods for identification, assessment, prevention, and therapy of ovarian cancer | |
| IL158206A0 (en) | Compositions and methods for the prevention and treatment of human prostate cancer | |
| AU2002257033A1 (en) | Agents and methods for the prevention of initial onset and recurrence of existing cancers | |
| AU2001238493A1 (en) | Methods and compositions for the identification, assessment, prevention and therapy of human cancers | |
| AU2074101A (en) | Compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer | |
| AU2596901A (en) | Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer | |
| AU2001259062A1 (en) | Compositions and methods for the therapy and diagnosis of lung cancer | |
| AU2002241720A1 (en) | Compositions, kits, and methods for identification, assessment, prevention, and therapy of ovarian cancer |